Skip to content

Prenatal Microarray Follow-Up Study

Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis: Follow-Up

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02160938
Enrollment
184
Registered
2014-06-11
Start date
2013-02-28
Completion date
2018-12-31
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Diseases

Keywords

microarray, prenatal, copy number variant, CNV, microdeletion, microduplication, genetic

Brief summary

The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.

Detailed description

Specifically the aims are as follows: 1. Determine the intellectual function of the children at age 3 years 2. Determine phenotypic characteristics other than intellectual function of the children at age 3 years 3. Determine the frequency of specific copy number variants discovered during routine prenatal diagnostic testing 4. Evaluate the educational, counseling and psychosocial implications of microarray testing as it is introduced as a standard prenatal diagnostic procedure.

Interventions

OTHER3-year follow-up

When the infants reach 24 months of age, the Study Follow-up Specialist will send all participants an age- appropriate Ages and Stages Questionnaire (ASQ) for completion. At the age of 3, the following exams will be performed and are described below: * The Vineland-II Adaptive Behavior Scale (VABS) * Wechsler Preschool and Primary Scale of Intelligence IV (WPPSI-IV), or Wechsler Intelligence Scale for Children - Fifth Edition (WISC-V, for siblings older than 7 years 7 months, when necessary) * Children will also be photographed (for review by the study dysmorphologist)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
National Human Genome Research Institute (NHGRI)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria for Enrollment into the 3 year Follow-up Cohort Inclusion Criteria 1. Singleton or multi-fetal pregnancy with a prenatal invasive procedure resulting in a diagnosis by microarray analysis of a microdeletion/duplication less than 10 Mbs, either pathogenic or of uncertain significance, which is reported to the patient. This includes: * Infants diagnosed during prenatal diagnostic studies performed at the10 pre-specified prenatal diagnostic centers * Infants diagnosed by analysis of microarrays performed at the collaborating laboratories * Infants referred through the Prenatal Microarray Resource Center website * Children who will be at least 3 years of age by January of 2018, and who had a prenatally detected CNV \<10 Mbs, either pathogenic or of uncertain significance OR 2. Children whose mothers were enrolled in the initial study (through July 2011) and who met inclusion criteria for follow-up in that phase, referred to as the Index cohort. This includes: * CNVs of uncertain or known significance, some of which were not reported to the patient * Mosaic findings by karyotype and/or microarray alone.

Exclusion criteria

1. Patient refusal to allow infant follow-up through the age of three 2. Patient not fluent in the English language 3. Patient under the age of 18 4. In surrogate pregnancies, the rearing parents are unavailable to give consent.

Design outcomes

Primary

MeasureTime frameDescription
Full Scale Intelligence Quotient (IQ) scoreage 3 yearsFull Scale IQ score from the Wechsler Preschool and Primary Scale of Intelligence IV or Wechsler Intelligence Scale for Children 5th edition

Secondary

MeasureTime frameDescription
Percent of subjects with seizure disordersage: up to 3 years
Percent of subjects with cerebral palsyage: up to 3 years
Percent of subjects with dysmorphic features diagnosed by dysmorphologistage 3 years
Percent of subjects with structural anomaliesage: up to 3 years
Verbal Comprehension composite scoreage: up to 3 yearsVerbal Comprehension composite score from the Wechsler Preschool and Primary Scale of Intelligence IV
Visual Spatial composite scoreage: up to 3 yearsVisual Spatial composite score from the Wechsler Preschool and Primary Scale of Intelligence IV
Working Memory composite scoreage: up to 3 yearsWorking Memory composite score from the Wechsler Preschool and Primary Scale of Intelligence IV
Percent of subjects with specific commonly occurring CNVsdetected prenatally
Daily Living Skills domain scoreage: up to 3 yearsDaily Living Skills domain score from the Vineland Adaptive Behavior Scale
Socialization domain scoreage: up to 3 yearsSocialization domain score from the Vineland Adaptive Behavior Scale
Motor Skills domain scoreage: up to 3 yearsMotor Skills domain score from the Vineland Adaptive Behavior Scale
Adaptive Behavior Composite scoreage: up to 3 yearsAdaptive Behavior Composite score from the Vineland Adaptive Behavior Scale
Age-adjusted Z scores for birth weightbirth
Age-adjusted Z scores for birth lengthbirth
Age-adjusted Z scores for head circumferencebirth
Communication domain scoreage: up to 3 yearsCommunication domain score from the Vineland Adaptive Behavior Scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026